Calcium carbonate

A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 &microM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1

A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 &microM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1

A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 &microM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1

Description1 tablet in 100 mL of water yields in 0.05 M NaHCO3, 0.05% NaN3, pH 9.6Carbonate bicarbonate buffer with azide has been used in a study to examine the effects of phorbol myristate acetate on acid secretion by the turtle urinary bladder to

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

InformationCav 2.2 blocker 1 Cav 2.2 blocker 1 (compound 9) is a N-type calcium channel (Cav 2.2) blocker for the treatment of pain with IC50 of 0.001 μM.TargetsCav 2.2 (Cell-free assay) 0.001 μM.

A potent, selective full agonist for BLT2 with an EC50 value of 20 nM activates BLT2 at significantly lower concentrations than LTB4 (EC50 = 170 nM) dose dependently increases intracellular calcium stores and induces ERK phosphorylation in CHO

A potent, selective full agonist for BLT2 with an EC50 value of 20 nM activates BLT2 at significantly lower concentrations than LTB4 (EC50 = 170 nM) dose dependently increases intracellular calcium stores and induces ERK phosphorylation in CHO